Study reveals long-term effects on child IQ of epilepsy drug valproate during pregnancy
January 22, 2013 in Medications
Research published today in the Lancet Neurology shows that taking the antiepileptic drug valproate during pregnancy affects the IQ of children up to the age of six.
Research published in 2009 showed that maternal valproate use during pregnancy affected children's IQ at three years old, leading the US Food and Drug Administration (FDA) to issue a warning that foetal valproate exposure is associated with impaired cognitive outcomes. The new research reports on the same group of children – whose mothers used one of four common antiepileptic drugs, including valproate, during pregnancy – at six years old. Due to the children's advanced age, the researchers were able to examine a wider range of cognitive indicators, such as verbal ability and memory, than in the earlier study. They also investigated the effect that folic acid supplementation in the mothers had on the IQ and reasoning ability of their children.
Between October 1999 and February 2004, the researchers, led by Professor Kimford Meador at Emory University in the US, recruited 305 pregnant women in the UK and the US, who were using a single drug to treat epilepsy (valproate, carbamazepine, lamotrigine, or phenytoin). At age six, children whose mothers had used valproate during pregnancy had reduced IQ (by 7-10 points), compared with children from mothers who had used the other antiepileptic drugs included in the study. Valproate exposure was also associated with worse verbal and memory abilities.
The effects of valproate on IQ and other cognitive abilities were dependent on the dose, with the children of women who took higher doses of the drug having lower IQs, verbal, non-verbal, memory, and executive abilities. However, the findings also suggest that IQ may improve with age for infants exposed to valproate or any of the other drugs studied, and that folic acid supplementation in mothers may improve IQ scores, the first time that this has been shown in a study of pregnant women with epilepsy. For some people, valproate is the only drug that can control their epilepsy, so the findings on dose-dependency and the potential positive effects of folic acid supplementation on IQ may prove particularly important.
According to Professor Meador, "These results build on our earlier work to show that valproate usage during pregnancy has a significant negative effect on children's IQ, which lasts beyond their earliest years. IQ at age six is strongly predictive of adult IQ and school performance, so our research suggests that valproate use during pregnancy is likely to have long-term negative effects on a child's IQ and other cognitive abilities. For many antiepileptic drugs, there is simply no research available on their effects on women and their children during pregnancy, and given that many women do not have the option of stopping medication during pregnancy, more research in this area is urgently needed."
More information: www.thelancet.com/… 3-X/abstract
Journal reference:
Lancet Neurology
Provided by
Lancet
-
Lower IQ found in children of women who took epilepsy drug
May 03, 2007 |
not rated yet |
0
-
Exposure to valproate during pregnancy can impair a child's cognitive development
Apr 15, 2009 |
not rated yet |
0
-
Epilepsy drug may increase risk of autism in children
Dec 01, 2008 |
not rated yet |
0
-
Epilepsy drugs may not affect IQ of breastfed babies, study says
Nov 24, 2010 |
not rated yet |
0
-
Epilepsy drug may increase risk of birth defects
Jul 21, 2008 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
How can there be villous adenoma in colon, if there are no villi there
20 hours ago
-
How can there be a term called "intestinal metaplasia" of stomach
May 21, 2013
-
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013
-
If you became brain-dead, would you want them to pull the plug?
May 17, 2013
-
MRI bill question
May 15, 2013
-
Ratio of Hydrogen of Oxygen in Dessicated Animal Protein
May 13, 2013
- More from Physics Forums - Medical Sciences
More news stories
Experts favor US approval of Merck sleeping pill (Update)
An independent panel of experts on Wednesday recommended US approval of a new Merck sleeping pill called suvorexant, but expressed concerns over the highest dosage and risks of drowsy daytime driving.
Medications
9 hours ago |
not rated yet |
0
Glaxo, US partnering to develop new antibiotics
GlaxoSmithKline PLC says it's starting an unusual collaboration with the U.S. government to develop several antibiotics for both bioterrorism threats and bacterial infections resistant to current medicines.
Medications
11 hours ago |
not rated yet |
0
Study finds new pneumococcal vaccine appears to be as safe as previously used vaccine
The new 13-valent pneumococcal conjugate vaccine (PCV13) appears to be as safe as the previous version used prior to 2010, the 7-valent pneumococcal conjugate vaccine (PCV7), according to a Kaiser Permanente study published ...
Medications
16 hours ago |
not rated yet |
0
Succesful results in developing oral vaccine against diarrhea
The University of Gothenburg Vaccine Research Institute (GUVAX) announces successful results in a placebo controlled phase I study of an oral, inactivated Escherichia coli diarrhea vaccine.
Medications
19 hours ago |
not rated yet |
0
New sleeping pill poised to hit US markets
An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.
Medications
May 21, 2013 |
4.2 / 5 (5) |
0
Slowing the aging process—only with antibiotics
Swiss scientists reveal the mechanism responsible for aging hidden deep within mitochondria—and dramatically slow it down in worms by administering antibiotics to the young.
Rate of bicycle-related fatalities significantly lower in states with helmet laws
Existing research shows that bicyclists who wear helmets have an 88 percent lower risk of brain injury, but researchers at Boston Children's Hospital found that simply having bicycle helmet laws in place showed a 20 percent ...
Researchers complete largest genetic sequencing study of human disease
Researchers from Queen Mary, University of London have led the largest sequencing study of human disease to date, investigating the genetic basis of six autoimmune diseases.
Brain can be trained in compassion, study shows
Until now, little was scientifically known about the human potential to cultivate compassion—the emotional state of caring for people who are suffering in a way that motivates altruistic behavior.
Having both migraines, depression may mean smaller brain
(HealthDay)—Migraines and depression can each cause a great deal of suffering, but new research indicates the combination of the two may be linked to something else entirely—a smaller brain.
Novel approach for influenza vaccination shows promise in early animal testing
A new approach for immunizing against influenza elicited a more potent immune response and broader protection than the currently licensed seasonal influenza vaccines when tested in mice and ferrets. The vaccine ...